| 骨髓增生异常综合征研究进展:第56届美国血液学会年会报道 |
| |
| 引用本文： | 孙谕,傅晋翔.骨髓增生异常综合征研究进展:第56届美国血液学会年会报道[J].白血病．淋巴瘤,2015,24(5):257-260. |
| |
| 作者姓名： | 孙谕 傅晋翔 |
| |
| 作者单位： | 215004,苏州大学附属第二医院血液科 |
| |
| 摘 要： | 第56届美国血液学会(ASH)年会上关于骨髓增生异常综合征(MDS)的报道中有大量对发病机制的研究,现主要就ASH会议对MDS基因突变的报告进行介绍.
|
| 关 键 词： | 骨髓增生异常综合征 发病机制 基因突变 美国血液学会年会 |
Recent progress of myelodysplastic syndrome: reports from the 56th American Society of Hematology annual meeting |
| |
| Sun Yu,Fu Jinxiang.Recent progress of myelodysplastic syndrome: reports from the 56th American Society of Hematology annual meeting[J].Journal of Leukemia & Lymphoma,2015,24(5):257-260. |
| |
| Authors: | Sun Yu Fu Jinxiang |
| |
| Abstract: | The myelodysplastic syndrome (MDS),which are characterized by the presence of ineffective hematopoetic stem cells.Research on pathogenesis and related epigetics has made significant progress in recent years,more and more abnormal cytogenetics and gene mutations are used for prognosis and treatment options for MDS.In the 56th American Society of Hematology (ASH) annual meeting,lots of gene mutations were introduced. |
| |
| Keywords: | Myelodysplastic syndrome Pathogenesis Gene mutations American Society of Hematology annual meeting |
| 本文献已被 万方数据 等数据库收录！ |
